Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant
Journal of Perinatology, 09/07/2011
Ramanathan R et al. – Poractant alfa treatment for respiratory distress syndrome (RDS) was associated with a significantly reduced likelihood of death when compared with calfactant and a trend toward reduced mortality when compared with beractant.




